[NESTLE] QoQ Cumulative Quarter Result on 31-Mar-2003 [#1]

Stock
[NESTLE] NESTLE (M) BHD
Announcement Date
30-Apr-2003
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2003
Quarter
31-Mar-2003 [#1]
Profit Trend
QoQ- -70.41%
YoY- 13.94%
Quarter Report
Latest QR
Upcoming QR
NESTLE's Result
NESTLE's Financial Summary
View:
Show?
Cumulative Result
31/12/03 30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 CAGR
Revenue 2,656,989 2,003,548 1,330,996 655,308 2,479,649 1,968,597 1,351,322 56.75%
PBT 202,117 159,254 115,225 71,731 234,204 200,679 133,772 31.57%
Tax -40,128 -34,957 -29,705 -17,711 -51,619 -42,749 -34,423 10.73%
NP 161,989 124,297 85,520 54,020 182,585 157,930 99,349 38.40%
-
NP to SH 161,989 124,297 85,520 54,020 182,585 157,930 99,349 38.40%
-
Tax Rate 19.85% 21.95% 25.78% 24.69% 22.04% 21.30% 25.73% -
Total Cost 2,495,000 1,879,251 1,245,476 601,288 2,297,064 1,810,667 1,251,973 58.16%
-
Net Worth 304,843 269,701 316,567 403,274 361,136 377,587 375,167 -12.89%
Dividend
31/12/03 30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 CAGR
Div 176,340 82,082 82,072 - 191,355 70,357 70,343 84.22%
Div Payout % 108.86% 66.04% 95.97% - 104.80% 44.55% 70.80% -
Equity
31/12/03 30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 CAGR
Net Worth 304,843 269,701 316,567 403,274 361,136 377,587 375,167 -12.89%
NOSH 234,494 234,522 234,494 234,461 234,504 234,526 234,479 0.00%
Ratio Analysis
31/12/03 30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 CAGR
NP Margin 6.10% 6.20% 6.43% 8.24% 7.36% 8.02% 7.35% -
ROE 53.14% 46.09% 27.01% 13.40% 50.56% 41.83% 26.48% -
Per Share
31/12/03 30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 CAGR
RPS 1,133.07 854.31 567.60 279.49 1,057.40 839.39 576.31 56.74%
EPS 69.08 53.00 36.47 23.04 77.86 67.34 42.37 38.40%
DPS 75.20 35.00 35.00 0.00 81.60 30.00 30.00 84.22%
NAPS 1.30 1.15 1.35 1.72 1.54 1.61 1.60 -12.89%
Adjusted Per Share Value based on latest NOSH - 234,461
31/12/03 30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 CAGR
RPS 1,133.04 854.39 567.59 279.45 1,057.42 839.49 576.26 56.75%
EPS 69.08 53.01 36.47 23.04 77.86 67.35 42.37 38.40%
DPS 75.20 35.00 35.00 0.00 81.60 30.00 30.00 84.22%
NAPS 1.30 1.1501 1.35 1.7197 1.54 1.6102 1.5999 -12.89%
Price Multiplier on Financial Quarter End Date
31/12/03 30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 CAGR
Date 31/12/03 30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 28/06/02 -
Price 21.80 21.00 20.50 20.20 20.00 20.20 20.50 -
P/RPS 1.92 2.46 3.61 7.23 1.89 2.41 3.56 -33.66%
P/EPS 31.56 39.62 56.21 87.67 25.69 30.00 48.38 -24.72%
EY 3.17 2.52 1.78 1.14 3.89 3.33 2.07 32.75%
DY 3.45 1.67 1.71 0.00 4.08 1.49 1.46 77.13%
P/NAPS 16.77 18.26 15.19 11.74 12.99 12.55 12.81 19.61%
Price Multiplier on Announcement Date
31/12/03 30/09/03 30/06/03 31/03/03 31/12/02 30/09/02 30/06/02 CAGR
Date 26/02/04 02/01/04 06/08/03 30/04/03 27/02/03 06/11/02 21/08/02 -
Price 22.10 21.80 20.80 20.00 19.50 19.30 20.30 -
P/RPS 1.95 2.55 3.66 7.16 1.84 2.30 3.52 -32.47%
P/EPS 31.99 41.13 57.03 86.81 25.04 28.66 47.91 -23.54%
EY 3.13 2.43 1.75 1.15 3.99 3.49 2.09 30.80%
DY 3.40 1.61 1.68 0.00 4.18 1.55 1.48 73.84%
P/NAPS 17.00 18.96 15.41 11.63 12.66 11.99 12.69 21.45%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment